Sign in
4

Changes in Ownership

Nautilus Biotechnology, Inc. Filed Acc 0001797672-26-000004

Options or other derivatives

  • Director acquired 45,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Akinsanya Karen Director 2026-06-18 Grant or award · Stock Option (Right to Buy) +45,000 45,000 D: show line 1 in the form
Loading xslF345X06/wk-form4_1782159237.xml…